Next-generation regulatory T cell therapy.
Ontology highlight
ABSTRACT: Regulatory T cells (Treg cells) are a small subset of immune cells that are dedicated to curbing excessive immune activation and maintaining immune homeostasis. Accordingly, deficiencies in Treg cell development or function result in uncontrolled immune responses and tissue destruction and can lead to inflammatory disorders such as graft-versus-host disease, transplant rejection and autoimmune diseases. As Treg cells deploy more than a dozen molecular mechanisms to suppress immune responses, they have potential as multifaceted adaptable smart therapeutics for treating inflammatory disorders. Indeed, early-phase clinical trials of Treg cell therapy have shown feasibility, tolerability and potential efficacy in these disease settings. In the meanti
SUBMITTER: Ferreira LMR
PROVIDER: S-EPMC7773144 | biostudies-literature | 2019 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA